Oxazinanes
Apexbio Technology LLC CLINAFLOXACIN-HYDROCHLORIDE
Clinafloxacin (hydrochloride) (CAS No 105956-99-8) is an investigational antibacterial agent belonging to the fluoroquinolone class known for its broad-spectrum activity Originating from chemical modifications to enhance antibacterial efficacy it targets bacterial DNA gyrase and topoisomerase IV crucial enzymes for DNA replication and transcription Clinafloxacin exhibits potent antibacterial activity in the nanomolar to low micromolar range against various gram-positive and gram-negative bacteria It is frequently used in cell models and animal studies to evaluate antibacterial efficacy and resistance mechanisms Additionally it is utilized in drug screening assays to explore new therapeutic options for bacterial infections Experimental concentrations typically depend on the specific research design allowing flexibility in applications across different models and conditions
Aobchem 3-Methyl-1 3-dihydro-2 1-benzoxaborol-1-ol | ≥95% | CAS 92203-40-2 | C8H9BO2 | 1g
3-Methyl-1 3-dihydro-2 1-benzoxaborol-1-ol | ≥95% | CAS 92203-40-2 | C8H9BO2 | 1g
eMolecules 212127-80-5 | 2-(2,5-Dihydro-3-furanyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | Synthonix - Stock | MFCD16996209 | 196.050 | C10H17BO3 | 95.000 | CC1(C)OB(OC1(C)C)C1=CCOC1 | 250mg | 525914654
2-(2,5-Dihydro-3-furanyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | Synthonix - Stock | 212127-80-5 | MFCD16996209 | 196.050 | C10H17BO3 | 95.000 | CC1(C)OB(OC1(C)C)C1=CCOC1 | 250mg | 525914654
Apexbio Technology LLC TRIMETAZIDINE-HYDROCHLORIDE
Trimetazidine (hydrochloride) (CAS No 13171-25-0) is a pharmacological agent primarily studied in the cardiovascular research field Originating from anti-ischemic drug development it functions by optimizing cellular metabolism under hypoxic conditions predominantly through the inhibition of long-chain 3-ketoacyl-CoA thiolase in the cardiac mitochondrial beta-oxidation pathway This action shifts fatty acid oxidation to glucose oxidation enhancing myocardial glucose consumption and efficiency during ischemic episodes Common in vitro activity occurs in the nanomolar to low micromolar range Trimetazidine is frequently used in various experimental applications including cell models like cardiomyocytes animal studies investigating myocardial protection and drug screening for cardiovascular therapies Experimental concentrations typically depend on the specific research design enabling a tailored approach to exploring its cardioprotective effects in different contexts